Author

Radi Hammad

Observed names: Hammad, Radi, R. Hammad

Institution: Ministry of Health and Population

Observed institution: Ministry of Health and Population

OpenAlex ID: A5072976334

Sofosbuvir plus ribavirin for treating Egyptian patients with hepatitis C genotype 4

2015 · Wahid Doss, Gamal Shiha, et al. · Journal of Hepatology · 145

Pathways to ensure universal and affordable access to hepatitis C treatment

2018 · Caitlin H. Douglass, Alisa Pedrana, et al. · BMC Medicine · 76

Innovative strategies for the elimination of viral hepatitis at a national level: A country case series

2019 · Sophia E. Schröeder, Alisa Pedrana, et al. · Liver International · 65

Ledipasvir/sofosbuvir with or without ribavirin for 8 or 12 weeks for the treatment of HCV genotype 4 infection: results from a randomised phase III study in Egypt

2018 · Gamal Shiha, Gamal Esmat, et al. · Gut · 51

Simeprevir plus sofosbuvir for eight or 12 weeks in treatment‐naïve and treatment‐experienced hepatitis C virus genotype 4 patients with or without cirrhosis

2016 · M. El Raziky, M. Gamil, et al. · Journal of Viral Hepatitis · 30

Evidence of sustained reductions in the relative risk of acute hepatitis B and C virus infections, and the increasing burden of hepatitis a virus infection in Egypt: comparison of sentinel acute viral hepatitis surveillance results, 2001–17

2019 · Maha Talaat, Salma Afifi, et al. · BMC Infectious Diseases · 23

Study of the effectiveness of a supported intervention package in reducing the risk of avian influenza human exposure through the reduction of infections in poultry: Egypt, 2006–2021

2025 · Manal Fahim, Walaa Alim, et al. · Virology Journal · 1

P1346 : Study protocol for a partly randomised, open-label phase IIA trial of once-daily simeprevir combined with sofosbuvir for the treatment of HCV genotype 4 infected patients with or without cirrhosis (OSIRIS)

2015 · M. El Raziky, M. Gamil, et al. · Journal of Hepatology · 1

Raising biosafety awareness in public health laboratories in Egypt: lessons from a governorate partnering competition

2026 · Abeer Abdelaziz, Nancy Elguindy, et al. · Journal of Biosafety and Biosecurity

Efficacy of Sofosbuvir Plus Ribavirin with and without Pegylated Interferon in Management of Egyptian Chronic Hepatitis C Patients

2017 · Magdy Al Dahshan, Samy Zaky, et al. · Afro-Egyptian Journal of Infectious and Endemic Diseases

Prevalence of thyroid dysfunction in Egyptian chronic hepatitis C patients treated with Pegylated interferon and Ribavirin

2011 · Sherif M. Naguib, Ahmed M. Hashem, et al. · The Egyptian Journal of Hospital Medicine

Works count: 13

Citation count: 392

H-index: 6

I10-index: 6